September 29, 2025

ICON plc (ICLR) Stock Analysis: An Investor’s Guide to Understanding Its 31.67% Upside Potential

Investors looking for exposure in the healthcare sector, particularly in diagnostics and research, may find ICON plc (NASDAQ: ICLR) an intriguing opportunity. Headquartered in Dublin, Ireland,..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating a Challenging Landscape with Promising Revenue Growth

Oscar Health, Inc. (NYSE: OSCR) operates at the intersection of healthcare and technology, a sector that continues to attract investor interest due to its transformative potential...

Akero Therapeutics (AKRO) Stock Analysis: A Promising Biotech with 61.92% Potential Upside

For investors with a keen interest in the biotechnology sector, Akero Therapeutics, Inc. (NASDAQ: AKRO) presents an intriguing opportunity. Specializing in the development of treatments for..

Sarepta Therapeutics, Inc. (SRPT) Investor Outlook: Unveiling Potential with a 24.59% Upside

Sarepta Therapeutics, Inc. (SRPT), a prominent player in the biotechnology sector, is capturing attention with its promising portfolio in RNA-targeted therapeutics and gene therapies. As a..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Unveiling a 13.58% Potential Upside with Robust Revenue Growth

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a prominent player in the biotechnology sector, is capturing significant attention from investors with its strong revenue growth and promising market..

Ascendis Pharma A/S (ASND)

⚠️ No article content returned.

..

Grifols, S.A. (GRFS) Stock Analysis: Unpacking a 24% Potential Upside with a Strategic Healthcare Edge

Grifols, S.A. (NASDAQ: GRFS), a prominent name in the healthcare sector and a key player in the global plasma-derived therapies market, is gaining attention from investors..

Avantor, Inc. (AVTR) Stock Analysis: A Closer Look at Its Valuation and Growth Potential

Avantor, Inc. (NYSE: AVTR) stands as a significant player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of..

BeOne Medicines Ltd. (ONC) Stock Analysis: A Biotechnology Powerhouse with 41.6% Revenue Growth and Substantial Upside

BeOne Medicines Ltd. (ONC), a Switzerland-based leader in the biotech sector, has been making waves in the oncology space. With its headquarters in Basel, the company..

IQVIA Holdings, Inc. (IQV)

⚠️ No article content returned.

..

Masimo Corporation (MASI) Stock Analysis: Evaluating the 32.65% Potential Upside for Investors

Investors seeking opportunities in the healthcare sector’s medical devices industry may find Masimo Corporation (NASDAQ: MASI) a compelling prospect. With a market capitalization of $7.68 billion,..

RadNet, Inc. (RDNT) Investor Outlook: Analyzing the Healthcare Giant’s 4.45% Potential Upside

RadNet, Inc. (NASDAQ: RDNT), a leading player in the healthcare sector, is capturing investor attention with its robust market presence in diagnostics and research. Based out..

Legend Biotech Corporation (LEGN) Stock Analysis: Significant Growth Potential with 129.77% Upside

Legend Biotech Corporation (NASDAQ: LEGN) is making waves in the biotechnology sector with its innovative approach to oncology treatments. Headquartered in Somerset, New Jersey, Legend Biotech..

Regencell Bioscience Holdings (RGC) Stock Analysis: Uncovering Growth Potential in TCM Innovation

Regencell Bioscience Holdings Limited (NASDAQ: RGC) is capturing attention in the healthcare sector for its pioneering work with Traditional Chinese Medicine (TCM). Based in Hong Kong,..

BioNTech SE (BNTX) Stock Analysis: Unpacking the 38.75% Potential Upside and Analyst Confidence

BioNTech SE (NASDAQ: BNTX) stands as a compelling player in the biotechnology sector, primarily recognized for its groundbreaking work in developing immunotherapies for cancer and infectious..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: A Biotech Powerhouse with 110% Potential Upside

Investors on the lookout for promising opportunities in the biotechnology sector should take a closer look at Telix Pharmaceuticals Limited (ASX: TLX), a dynamic player in..

Alkermes plc (ALKS) Stock Analysis: Unpacking a 49.54% Potential Upside for Investors

Alkermes plc (NASDAQ: ALKS), a noteworthy player in the healthcare sector, stands out as a promising investment opportunity with a potential upside of 49.54%. With its..

Globus Medical, Inc. (GMED) Stock Analysis: Exploring a 44% Potential Upside with Robust Revenue Growth

Investors seeking opportunities in the healthcare sector might find Globus Medical, Inc. (NYSE: GMED) an intriguing prospect. This U.S.-based medical device company, with a market cap..

Waters Corporation (WAT)

⚠️ No article content returned.

..

Haleon plc (HLN) Investor Outlook: Unpacking a 31.88% Potential Upside in the Healthcare Sector

Haleon plc (HLN) stands as a significant player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of..

Search

Funds

September 29, 2025

Search

Funds

September 29, 2025

FTSE 100

Funds